| Literature DB >> 26416690 |
Fauzia Akhter Huda1, Anisuddin Ahmed2, Evelyn Rebecca Ford3, Heidi Bart Johnston4.
Abstract
BACKGROUND: Abortion related deaths as a proportion of maternal mortality appears to have fallen dramatically in Bangladesh from 5 % in 2001 to 1 % in 2010. Yet complications from menstrual regulation (MR) and unsafe abortion continue to cause deleterious health, economic and social consequences for women in the country.Entities:
Mesh:
Year: 2015 PMID: 26416690 PMCID: PMC4587727 DOI: 10.1186/s12913-015-1115-6
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Signal functions for safe menstrual regulation and abortion care (SMRAC)
| Signal functions for basic SMRAC services | Signal functions for comprehensive SMRAC services |
|---|---|
| ● Administer essential antibiotics |
|
| ● Administer intravenous fluids | |
| ● Administer oxytocics | ● Perform safe, legal abortion for uterine size >12 weeks, for all legal indications |
| ● Perform removal of retained products for uterine size ≤12 weeks | ● Perform removal of retained products for uterine size >12 weeks |
| ● Perform MR for uterine size ≤10 weeks and/or safe, legal abortion (≤12 weeks) | ● Perform blood transfusion |
| ● Provide post-MR and post-abortion contraception | ● Perform laparotomy |
Table adapted from Healy et al. [9], originally adapted from UN guidelines (Maine et al. [14])
Seven Indicators for measuring SMRAC
| SMRAC indicators | Definition | Recommendation |
|---|---|---|
|
| ||
| 1. Amount of SMRAC services available | Number of facilities providing basic and comprehensive SMRAC | For every 500,000 population: 5 SMRAC facilities, at least 1 of which offers comprehensive SMRAC |
|
| ||
| 2. Distribution of SMRAC facilities | Number of facilities providing basic and comprehensive SMRAC in sub national areas | Minimum: 100 % of sub-national areas have adequate level of SMRAC as recommended in indicator 1 |
|
| ||
| 3. Proportion of women treated for obstetric complications that are MR/abortion related | Numerator: number of women with MR/abortion complications treated at a facility in a given period; | Over time, a declining percentage of women with abortion/MR complications |
| Denominator: number of all women with obstetric complications treated at facility in the same time period | ||
|
| ||
| 4. Proportion of women treated for MR/abortion complications that are serious | Numerator: number of women with serious MR/abortion complications treated at a facility in a given period; Denominator: number of all women with any MR/abortion complications treated at facility in the same time period | Over time a declining percentage of women with serious MR/abortion complications |
|
| ||
| 5. Proportion of women who receive MR and safe, legal abortion among all women receiving MR/abortion care | Numerator: number of women receiving MR and safe, legal abortion procedures at a facility in a given time period | Over time, a shift towards a higher proportion of women receiving MR and safe, legal abortion |
| Denominator: number of all women receiving MR and abortion-related services in facility in the same time period | Recommended level: Approaching 100 % | |
|
| ||
| 6. Proportion of uterine evacuations performed with appropriate technology | Numerator: number of uterine evacuation procedures performed with appropriate technology at facility in a given period. | Over time, a shift toward a higher proportion of procedures performed with appropriate technology as per WHO recommendationsa |
| Denominator: number of all uterine evacuation procedures performed at facility within the same time period | Recommended level: 100 % | |
|
| ||
| 7. Proportion of women receiving MR, safe, legal abortion, or treatment for MR/abortion complications who obtain contraception before leaving facility | Numerator: number of women receiving MR, safe, legal abortion or treatment for MR/abortion complications who obtain contraception before leaving facility | At least 60 % of all women receiving MR/abortion services accept contraception |
| Denominator: number of women receiving MR, safe, legal abortion, or treatment for MR/abortion complications in facility in the same time period. | ||
Adapted from Healy et al. [9]
aWHO has provided evidence-based guidance on the preferred methods of uterine evacuation for different stages of pregnancy [17]
Signal functions provided by health facilities in the study area
| Signal function | Baseline | Endline | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ( | ( | |||||||||||
| FWC | MCWC | UHC | Dist. Hosp. | Private | Total | FWC | MCWC | UHC | Dist. Hosp. | Private | Total | |
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Administration of antibiotic | 0 | 1 | 7 | 1 | 21 | 30 | 0 | 1 | 7 | 1 | 20 | 29 |
| Administration of intravenous fluid | 0 | 1 | 7 | 1 | 22 | 31 | 1 | 1 | 7 | 1 | 19 | 29 |
| Administration of uterotonics | 0 | 1 | 7 | 1 | 23 | 32 | 0 | 1 | 7 | 1 | 20 | 29 |
| Removal of retained products (≤12 weeks) | 0 | 0 | 8 | 1 | 18 | 27 | 0 | 0 | 7 | 1 | 18 | 26 |
| Post-procedure contraception | 23 | 1 | 4 | 0 | 4 | 32 | 24 | 1 | 5 | 0 | 6 | 36 |
| MR (≤10 weeks) and/or safe, legal abortion (≤12 weeks) | 28 | 1 | 4 | 0 | 6 | 39 | 25 | 1 | 5 | 0 | 6 | 37 |
| Basic SMRAC facilities (20 recommended: 4 per 500,000 population) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Removal of retained products (>12 weeks) | 0 | 0 | 6 | 1 | 13 | 20 | 0 | 0 | 6 | 1 | 15 | 22 |
| Blood transfusion | 0 | 0 | 4 | 1 | 18 | 23 | 0 | 0 | 4 | 1 | 19 | 24 |
| Laparotomy | 0 | 0 | 2 | 1 | 18 | 21 | 0 | 0 | 2 | 1 | 16 | 19 |
| Safe, legal abortion (>12 weeks) | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 2 | 1 | 1 | 4 |
| Comprehensive SMRAC facilities (5 recommended:1 per 500,000 population) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fig. 1Distribution of health facilities in study area, Jessore-2009
Contraceptive acceptance following MR and PAC during the project period
| Case definition | Number of patients /clients | Received FP methodsa | Received FP referralb | Total receiving FP referral or supplies | |||
|---|---|---|---|---|---|---|---|
| No. | % | No. | % | No. | % | ||
| Care for MR | 9671 | 7233 | 75 | 26 | 0.3 | 7259 | 75 |
| Care for PAC | 3067 | 69 | 2 | 405 | 13 | 474 | 15 |
aDefined as leaving the facility with a contraceptive method
bDefined as referred to another facility for contraceptive services
Safe menstrual regulation and abortion care indicators (Indicators 3–7)
| Indicator 3 | Baseline | End line | Total |
|
|---|---|---|---|---|
| Abortion-related complications as a percentage of obstetric complications | (Jan to Dec 2008) | (Aug to Oct 2009) | (sig. in change from baseline to endline) | |
| NGO (%) | 54.12 | 26.42 | 45.66 | 0.000 |
| 368/680 | 79/299 | 447/979 | ||
| Private (%) | 68.08 | 36.30 | 57.00 | 0.000 |
| 561/824 | 200/551 | 761/1335 | ||
| Public (%) | 44.16 | 24.56 | 38.79 | 0.000 |
| 1062/2405 | 223/908 | 1285/3313 | ||
| Indicator 4 | ||||
| Serious abortion-related complications as a percentage of all abortion-related complications by type of facility | ||||
| NGO (%) | 0.27 | 10.13 | 2.01 | 0.000 |
| 1/368 | 8/79 | 9/447 | ||
| Private (%) | 23.53 | 9.00 | 19.71 | 0.000 |
| 132/561 | 18/200 | 150/761 | ||
| Public (%) | 11.21 | 13.00 | 11.52 | 0.4220 |
| 119/1062 | 29/223 | 148/1285 | ||
| Indicator 5 | ||||
| Proportion of all women receiving abortion services who receive MR or safe, legal abortions | ||||
| NGO (%) | 92.92 | 92.94 | 92.92 | 0.990 |
| 4829/5197 | 1040/1119 | 5869/6316 | ||
| Private (%) | 1.23 | 33.33 | 12.33 | 0.000 |
| 7/568 | 100/300 | 107/868 | ||
| Public (%) | 57.47 | 68.94 | 60.03 | 0.000 |
| 1435/2497 | 495/718 | 1930/3215 | ||
| Indicator 6 | ||||
| Proportion of uterine evacuation procedures performed with recommended technology | ||||
| NGO (%) | 95.36 | 94.93 | 95.28 | 0.531 |
| 4829/5064 | 1048/1104 | 5877/6168 | ||
| Private (%) | 4.66 | 33.67 | 14.56 | 0.000 |
| 27/579 | 101/300 | 128/879 | ||
| Public (%) | 67.17 | 67.36 | 67.22 | 0.964 |
| 1543/2297 | 487/723 | 2030/3020 | ||
| Indicator 7 | ||||
| Proportion of women receiving MR or abortion services who obtained contraception before leaving the facility | ||||
| NGO (%) | 58.40 | 89.10 | 63.84 | 0.000 |
| 3035/5197 | 997/1119 | 4032/6316 | ||
| Private (%) | 0.00 | 29.67 | 10.25 | 0.000 |
| 0/568 | 89/300 | 89/868 | ||
| Public (%) | 45.33 | 58.22 | 48.21 | 0.000 |
| 1132/2497 | 418/718 | 1550/3215 |